<DOC>
	<DOCNO>NCT00523549</DOCNO>
	<brief_summary>The purpose study determine effect treatment valsartan + amlodipine target systolic blood pressure ( SBP ) &lt; 130 mmHg compare Joint National Commission Treatment Hypertension 7 recommend target SBP &lt; 140 mmHg intrinsic diastolic property myocardium patient hypertension echocardiographic evidence diastolic dysfunction .</brief_summary>
	<brief_title>The Effects Systolic Blood Pressure Lowering Diastolic Function Using Valsartan + Amlodipine Patients With Hypertension Diastolic Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Age 45 year old Male female patient eligible . Female patient must postmenopausal one year , surgically sterile , use effective contraceptive method double barrier method spermicide , intrauterine device , hormonal contraceptive . Postmenopausal woman stable dose hormone replacement therapy ( HRT ) least three ( 3 ) month prior screen visit eligible study . Uncontrolled systolic hypertension maximum two ( 2 ) antihypertensive medication time screen . Echocardiographic ejection fraction â‰¥50 % evidence diastolic dysfunction . Provide write informed consent participate study prior screen study procedure Have ability communicate well comply study requirement Severe hypertension define MSSBP &gt; 200 mmHg and/or MSDBP &gt; 120 mmHg . History secondary cause hypertension include limited : coarctation aorta , hyperaldosteronism , unilateral bilateral renal artery stenosis , Cushing 's disease , pheochromocytoma , polycystic kidney disease , etc . Ejection fraction &lt; 50 % History stroke , transient ischemic attack , myocardial infarction , coronary artery bypass graft surgery , unstable angina pectoris within 6 month screen Presence clinically significant ventricular supraventricular arrhythmia ( e.g . atrial fibrillation/flutter ) History congestive heart failure History diabetes mellitus History renal impairment serum creatinine &gt; 2.0 mg/dL screening , history dialysis , history nephritic syndrome Antihypertensive therapy three ( 3 ) medication time screen Active and/or treat malignancy organ system within twelve ( 12 ) month enrollment , exception localize basal cell carcinoma skin Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test ( &gt; 5 mIU/ml ) Women childbearing potential ( WOCBP ) , define woman physiologically capable become pregnant , include woman whose career , lifestyle , sexual orientation precludes intercourse male partner woman whose partner sterilize vasectomy mean , UNLESS meet follow definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/m 6 week post surgical bilateral oophorectomy without hysterectomy OR use one follow acceptable method contraception : barrier method spermicidal agent , intrauterine device , hormonal contraceptive , total abstinence discretion investigator case age , career , lifestyle , sexual orientation patient ensure compliance . Periodic abstinence ( e.g. , calendar , ovulation , symptothermal , postovulation method ) withdrawal acceptable method contraception . Reliable contraception maintain throughout study Any surgical medical condition might significantly alter absorption , distribution , metabolism , excretion drug include , limited , follow : history major gastrointestinal tract surgery gastrectomy , gastroenterostomy , bowel resection , gastric bypass , gastric stapling , gastric banding , currently active , active inflammatory bowel syndrome within 12 month prior Visit 1 , currently active gastritis , ulcer , gastrointestinal/rectal bleeding , urinary tract obstruction regard clinically meaningful investigator Pancreatic injury , pancreatitis evidence impair pancreatic function/injury within 12 month prior Visit 1 Any serum AST ALT elevation two ( 2 ) time upper limit normal Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>systolic blood pressure</keyword>
	<keyword>diastolic dysfunction</keyword>
	<keyword>valsartan</keyword>
	<keyword>amlodipine</keyword>
</DOC>